New AI-Powered Free Company Valuation tool for any company in the world. Upload a PDF financial statement to receive an instant report with customizable forecasts, credit score, default probability and key financial metrics. Try Now for Free →
- Get an AI-powered company valuation or credit risk report in just 2 minutes
- Get reports of any company in the world with a financial statement in any language
- Upload a PDF financial statement to receive an instant report with customizable forecasts, credit score, default probability and key financial metrics
LEO PHARMA A/S — Credit Rating and Financial Key Figures
Credit rating
Company information
About LEO PHARMA A/S
LEO PHARMA A/S (CVR number: 56759514K) is a company from BALLERUP. The company reported a net sales of 13499 mDKK in 2025, demonstrating a growth of 8.4 % compared to the previous year. The operating profit percentage was at 16.9 % (EBIT: 2279 mDKK), while net earnings were 2489 mDKK. The profitability of the company measured by Return on Assets (ROA) was 11.8 %, which can be considered good but Return on Equity (ROE) was 62.5 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 25.7 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. LEO PHARMA A/S's liquidity measured by quick ratio was 0.7 which is at a low level. Thus, the company may face difficulties in addressing its short-term obligations with its available liquid assets.
Financial information
See financialsNet sales (mDKK)
EBIT (mDKK)
Profitability
Solidity
Key figures (mDKK)
See financials2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Volume | |||||
| Net sales | 9 957.00 | 10 641.00 | 11 392.00 | 12 453.00 | 13 499.00 |
| Gross profit | 5 995.00 | 6 283.00 | 7 200.00 | 7 518.00 | 8 240.00 |
| EBIT | -4 156.00 | -3 311.00 | -1 699.00 | -1 143.00 | 2 279.00 |
| Net earnings | -4 868.00 | -4 110.00 | -3 607.00 | -1 776.00 | 2 489.00 |
| Shareholders equity total | 5 537.00 | 1 946.00 | 4 525.00 | 2 704.00 | 5 262.00 |
| Balance sheet total (assets) | 23 695.00 | 22 932.00 | 20 951.00 | 20 151.00 | 20 445.00 |
| Net debt | 10 121.00 | 13 972.00 | 10 530.00 | 10 764.00 | 9 185.00 |
| Profitability | |||||
| EBIT-% | -41.7 % | -31.1 % | -14.9 % | -9.2 % | 16.9 % |
| ROA | -17.4 % | -14.2 % | -7.5 % | -4.9 % | 11.8 % |
| ROE | -78.0 % | -109.8 % | -111.5 % | -49.1 % | 62.5 % |
| ROI | -22.5 % | -18.6 % | -9.5 % | -6.2 % | 15.1 % |
| Economic value added (EVA) | -5 132.22 | -4 158.50 | -3 030.60 | -1 820.98 | 917.55 |
| Solvency | |||||
| Equity ratio | 23.4 % | 8.5 % | 21.6 % | 13.4 % | 25.7 % |
| Gearing | 190.6 % | 731.9 % | 237.5 % | 406.5 % | 179.0 % |
| Relative net indebtedness % | 178.0 % | 194.7 % | 142.3 % | 138.3 % | 110.7 % |
| Liquidity | |||||
| Quick ratio | 0.6 | 0.6 | 0.8 | 0.6 | 0.7 |
| Current ratio | 1.2 | 1.4 | 1.8 | 1.5 | 1.4 |
| Cash and cash equivalents | 432.00 | 270.00 | 216.00 | 227.00 | 235.00 |
| Capital use efficiency | |||||
| Trade debtors turnover (days) | 82.6 | 73.3 | 68.6 | 69.4 | 82.2 |
| Net working capital % | 11.9 % | 21.9 % | 32.7 % | 22.1 % | 18.2 % |
| Credit risk | |||||
| Credit rating | BB | BB | BB | BB | BBB |
Variable visualization
Roles
Companies in the same industry
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.